Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of toll-like receptors and retinoic acid inducible gene-I

Journal of Medical Virology

Volumn 80, Issue 6, 2008, Pages 980-988

  Miyazaki, Masanori ^a   Kanto, Tatsuya ^a   Inoue, Michiyo ^a   Itose, Ichiyo ^a   Miyatake, Hideki ^a   Sakakibara, Mitsuru ^a   Yakushijin, Takayuki ^a   Kakita, Naruyasu ^a   Hiramatsu, Naoki ^a   Takehara, Tetsuo ^a   Kasahara, Akinori ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; Innate immunity; Myeloid dendritic cell; RIG I; TLR3

Indexed keywords

AMINO ACID DERIVATIVE; BETA INTERFERON; CYTOKINE; INTERFERON; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN; PALMITOYL 3 CYSTEINYLSERYLLYSINE 4; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; TIR DOMAIN CONTAINING ADAPTER INDUCING INTERFERON BETA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADULT; ANALYTIC METHOD; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADULT; CASE-CONTROL STUDIES; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MYELOID CELLS; POLY I-C; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS;

HEPATITIS C VIRUS;

EID: 43249118725     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21174     Document Type: Article

References (25)

1. Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, Lemon SM, Lanford RE. 2004. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 78: 13779-13792.
2. Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, Chisari FV. 2001. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33:267-276.
3. Doyle SE, O'Connell R, Vaidya SA, Chow EK, Yee K, Cheng G. 2003. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. J Immunol 170:3565-3571.
4. El-Serag HB, Anand B, Richardson P, Rabeneck L. 2003. Association between hepatitis C infection and other infectious diseases: A case for targeted screening? Am J Gastroenterol 98:167-174.
5. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491-496.
6. Foy E, Li K, Sumpter R Jr, Loo YM, Johnson CL, Wang C, Fish PM, Yoneyama M, Fujita T, Lemon SM, Gale M Jr. 2005. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci USA 102:2986-2991.
7. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
8. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995.
9. Kaimori A, Kanto T, Kwang Limn C, Komoda Y, Oki C, Inoue M, Miyatake H, Itose I, Sakakibara M, Yakushijin T, Takehara T, Matsuura Y, Hayashi N. 2004. Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin. Virology 324:74-83.
10. Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, Yakushijin T, Oki C, Itose I, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. 2004. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190:1919-1926.
11. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52.
12. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M Jr, Lemon SM. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102:2992-2997.
13. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM. 2006. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 80:866-874.
14. Noborg U, Gusdal A, Pisa EK, Hedrum A, Lindh M. 1999. Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test. J Clin Microbiol 37:2793-2797.
15. Pawlotsky JM, Bouvier-Alias M, Hezode C, Darthuy F, Remire J, Dhumeaux D. 2000. Standardization of hepatitis C virus RNA quantification. Hepatology 32:654-659.
16. Riordan SM, Skinner NA, Kurtovic J, Locarnini S, McIver CJ, Williams R, Visvanathan K. 2006. Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury. Inflamm Res 55:279-285.
17. Rodrigue-Gervais IG, Jouan L, Beaule G, Sauve D, Bruneau J, Willems B, Sekaly RP, Lamarre D. 2007. Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J Virol 81:5537-5546.
18. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M Jr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and L GP2. Proc Natl Acad Sci USA 104:582-587.
19. Spanakis NE, Garinis GA, Alexopoulos EC, Patrinos GP, Menounos PG, Sklavounou A, Manolis EN, Gorgoulis VG, Valis D. 2002. Cytokine serum levels in patients with chronic HCV infection. J Clin Lab Anal 16:40-46.
20. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79:2689-2699.
21. Szabo G, Dolganiuc A. 2005. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 210:237-247.
22. Tavakoli S, Schwerin W, Rohwer A, Hoffmann S, Weyer S, Weth R, Meisel H, Diepolder H, Geissler M, Galle PR, Lohr HF, Bocher WO. 2004. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol 85:2829-2836.
23. van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG, Kwekkeboom J, Janssen HL. 2004. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40:738-746.
24. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B. 2002. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169:3447-3458.
25. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737.